Asymptomatic cardiomyopathy in children and adolescents with type 1 diabetes mellitus: Association of echocardiographic indicators with duration of diabetes mellitus and metabolic parameters

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 5, 2006, Pages 713-726

  Adal, Erdal ^a,c   Koyuncu, Güven ^a   Aydin, Ahmet ^a   Çelebi, Ahmet ^b   Kavunoǧlu, Gülsev ^a   Ca̧m, Halit ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Adeloscent; Carnitine; Child; Diabetic cardiomyopathy; Echocardiography; Type 1 diabetes mellitus

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETYLCARNITINE; CARNITINE; CHOLESTEROL; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEISURE; LIPID ANALYSIS; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; VELOCITY;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CARDIOMYOPATHIES; CARNITINE; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIASTOLE; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FUNCTION TESTS; HUMANS; INFANT; LIPIDS; MALE; SYSTOLE;

EID: 33745247442     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol 1974; 34: 29-34.
2. Kannel WB, McGee DL. Diabetes and cardiovascular disease; the Framingham Study. JAMA 1979; 241: 2035-2038.
3. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA 1974; 229: 1749-1754.
4. Blumenthal HT, Alex M, Goldberg S. A study of lesions of the intramural coronary artery branches in diabetes mellitus. Arch Pathol 1960; 70: 27-41.
5. Rubler S, Dlugash J, Yüceoǧlu YZ, Kumral K, Branwood AW, Brishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30: 595-602.
6. Sanderson JE, Brown DJ, Rivellese A, Kohner E. Diabetic cardiomyopathy? An echocardiogaphic study of young diabetics. Br Med J 1978; 1: 404-407.
7. Shapiro LM, Leatherdale BA, Mackinnon J, Fletcher RF. Left ventricular function in diabetes mellitus II: relation between clinical features and left ventricular function. Br Heart J 1981; 45: 129-132.
8. Danielsen R, Nordrehaug JE, Lien E, Vik-Mo H. Subclinical left ventricular abnormalities in young subjects with long-term type I diabetes mellitus detected by digitized M-mode echocardiography. Am J Cardiol 1987; 60: 143-146.
9. Takenaka K, Sakamoto T, Amana K, Oku J, Murakami T, Toda I, Kawakuba K, Sugimoto T. Left ventricular filling determined by Doppler echocardiography in diabetes mellitus. Am J Cardiol 1988; 61: 1140-1143.
10. Paillole C, Daham M, Paycha F, Solal AC, Passa P, Gourgon R. Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetes mellitus. Am J Cardiol 1989; 64: 1010-1016.
11. Schmidt A, Großmann G, Hauner H, Koenig W, Jansen T, Stauch M, Hombach V. Left ventricular function and wall thickness in long-term insulin-dependent diabetes mellitus: an echocardiographic study. J Intern Med 1991; 229: 527-531.
12. Galderisi M, Anderson K, Wilson PWF, Levy D. Echocardiographic evidence for existence of a distinct diabetic cardiomyopathy (the Framingham Study). Am J Cardiol 1991; 68: 85-89.
13. Illan F, Valdes-Chavarri M, Tebar J, Garcia A, Pascual H, Soria F, Hernandez A, Vicente T. Anatomical and functional cardiac abnormalities in type I diabetes. Clin Investig 1992; 70: 403-410.
14. Raev D. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care 1994; 17: 633-639.
15. Lo SSS, Leslie RDG, Sutton MSJ. Effects of type I diabetes mellitus on cardiac function; a study of monozygotic twins. Br Heart J 1995; 73: 450-455.
16. Fraser GE, Luke R, Thompson S, Smith H, Carter S, Sharpe N. Comparison of echocardiographic variables between type I diabetics and normal controls. Am J Cardiol 1995; 75: 141-145.
17. Becker DJ. Complication of insulin-dependent diabetes mellitus in childhood and adolescence. In: Lifshitz F, ed. Pediatric Endocrinology: A Clinical Guide, 3rd Ed. New York: Marcel Dekker Inc., 1996; 583-605.
18. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328: 1676-1685.
19. Clark CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995; 332: 1210-1217.
20. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
21. Tarumi N, Iwasaka T, Takahashi N, Sugiura T, Morita Y, Sumimoto T, Niskiue T, Inada M. Left ventricular diastolic filling properties in diabetic patients during isometric exercise. Cardiology 1993; 83: 316-323.
22. Lababidi Z, Goldstein D, England J. High prevalence of cardiomyopathy in young diabetics. Diabetologia 1981; 30 (Suppl 1): Abst 13.
23. Friedman NE, Levitsky LL, Edidin DV, Vitullo DA, Lacina SJ, Chiemmongkoltip P. Echocardiographic evidence for impaired myocardial performance in children with type I diabetes mellitus. Am J Med 1982; 73: 846-850.
24. Juhasz M, Silberbauer K, Ohrenberger G, Winhofer G. Left ventricular function in young type I diabetic patients: a Doppler echocardiographic study. Wien Klin Wochenschr 1990; 102: 70-74.
25. Hausdorf G, Rieger U, Koepp P. Cardiomyopathy in childhood diabetes mellitus: incidence, time at onset, and relation to metabolic control. Int J Cardiol 1988; 19: 225-236.
26. Borow KW, Jaspan JB, Williams KA, Neumann A, Wolinski-Walley P, Lang R. Myocardial mechanics in young adult patients with diabetes mellitus - effects of altered load, inotropic state and dynamic exercise. J Am Coll Cardiol 1990; 7: 1508-1517.
27. Schwingshandl J, Word C, Silink M, Sholler G. Echocardiography load-independent indices of contractility in children and adolescents with type I diabetes: effects of metabolic control and insulin on left ventricular performance. Pediatr Cardiol 1995; 16: 1-5.
28. Thuesen L, Christiansen JS, Schmitz O, Christensen NJ, Orskov H, Henningsen P. Increased myocardial contractility during intravenous insulin infusion in type I diabetic patients: an echocardiographic study. Scand J Clin Invest 1988; 48: 275-284.
29. Gøtzsche O, Sørensen K, McIntyre B, Henningsen P. Reduced left ventricular afterload and increased contractility in children with insulin-dependent diabetes mellitus: an M-mode and Doppler echocardiographic evaluation of left ventricular diastolic and systolic function. Pediatr Cardiol 1991; 12: 69-73.
30. Kimball TR, Daniels SR, Khoury PR, Magnotti RA, Turner AM, Dolan LM. Cardiovascular status in young patients with insulin-dependent diabetes mellitus. Circulation 1994; 90: 357-361.
31. Riggs TW, Transue D. Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. Am J Cardiol 1990; 65: 899-902.
32. Ragonese P. Ferrazza A, Paolini A, Reale F. Left ventricular diastolic filling in type I diabetes mellitus: a pulsed Doppler echocardiographic study. Eur J Med 1992; 1: 69-74.
33. Cerruti F, Vigo A, Sacchetti C, Bessone A, Barrattia G, Morello M, Casalucci D, Gastaldi L. Evaluation of left ventricular diastolic function in insulin dependent diabetic children by M-mode and Doppler echocardiography. Panminerva Med 1994; 36: 109-114.
34. Salazar J, Rivas A, Rodriguez M, Felipe J, Garcia MD, Bone J. Left ventricular function determined by Doppler echocardiography in adolescents with type I (insulin-dependent) diabetes mellitus. Acta Cardiol 1994; 49: 435-439.
35. Visioli O, Pasini E, De Giuli F, Ferrari R. Molecular mechanism of action of L-carnitine in treatment of myocardial disorders at the experimental level. In: Ferrari R, Di Mauro S, Sherwood G, eds. L-Carnitine and its Role in Medicine: From Function to Therapy. San Diego, CA: Academic Press Ltd., 1992; 237-263.
36. Dhalla NS, Dixon IMC, Shah KR, Ferrari R. Beneficial effects of L-carnitine and derivatives on heart membranes in experimental diabetes. In: Ferrari R, Di Mauro S, Sherwood G, eds. L-Carnitine and its Role in Medicine: From Function to Therapy. San Diego, CA: Academic Press Ltd., 1992; 411-426.
37. Vary TE, Neely JR. A mechanism for reduced myocardial carnitine levels in diabetic animals. Am J Physiol 1982; 243: H154-158.
38. Feavray D, Idell-Wenger JA, Neely JR. Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ Res 1979; 44: 322-329.
39. Fogle PS, Bieber LL. Effect of streptozotocin on carnitine and carnitine acyl transferases in rat heart, liver, and kidney. Biochem Med 1976; 22: 119-126.
40. Pearson DJ, Tubbs PK. Carnitine and derivatives in rat tissues. Biochem J 1967; 105: 953-963.
41. Genuth SM, Hoppel CL. Plasma and urine carnitine in diabetic ketosis. Diabetes 1979; 28: 1083-1087.
42. Hoppel CL, Genuth SM. Urinary excretion of acetyl-carnitine during human diabetic and fasting ketosis. Am J Physiol 1982; 243: E168-172.
43. Okuda Y, Kawai K, Murayama Y, Yamashita K. Postprandial changes in plasma ketone body and carnitine levels in normal and insulin dependent diabetic subjects. Endocrinol Jpn 1987; 34: 415-422.
44. Cederblad G, Lundhohn K, Schersten T. Carnitine concentrations in skeletal muscle tissue from patients with diabetes mellitus. Acta Med Scand 1977; 202: 305-306.
45. Cederblad G, Hermansson G, Ludvigsson J. Plasma and urine carnitine in children with diabetes mellitus. Clin Chim Acta 1982; 125: 207-217.
46. Soltesz G, Melegh B, Sandor A. The relationship between carnitine and ketone body levels in diabetic children. Acta Paediatr Scand 1983; 72: 511-515.
47. Winter SC, Simon M, Zorn EM, Szabo-Aczel S, Vance WH, O'Hara T, Higashi L. Relative carnitine insufficiency in children with type I diabetes mellitus. Am J Dis Child 1989; 143: 1337-1339.
48. Rodrigues B, Xiang H, McNeill JH. Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 1988; 37: 1358-1364.
49. Lopaschuk GD, Tahiliani AG, Vadlamudi RVSV, Katz S, McNeill JH. Cardiac sarcoplasmic reticulum function in insulin- or carnitine-treated diabetic rats. Am J Physiol 1983; 245: H969-976.
50. Pieper GM, Murray WJ. In vivo and in vitro intervention with L-carnitine prevents abnormal energy metabolism in isolated diabetic rat heart chemical and phosphorus-31 NMR evidence. Biochem Med Metab Biol 1987; 38: 111-120.
51. Paulson DJ, Schmidt MJ, Traxler JS, Ramacci MT, Shug AL. Improvement of myocardial function in diabetic rats after treatment with L-carnitine. Metabolism 1984; 33: 358-363.
52. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
53. Teicholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence and absence of asynergy. Am J Cardiol 1976; 37: 7-12.
54. Devereux RB, Recihek N. Echocardiographic determination of left ventricular mass in men: anatomic validation of the method. Circulation 1977; 55: 613-617.
55. Silverman NH. Quantitative methods to enhance morphological information using M-mode, Doppler, and cross-sectional ultrasound. In: Silvermann NH, ed. Pediatric Echocardiography. Baltimore, MA: Williams-Wilkins Co., 1993; 35-108.
56. Quinones MA. Doppler assessment of left ventricular diastolic function. In: Nanda NC, ed. Doppler Echocardiography, 2nd Ed. Philadelphia, PA: Lea-Febiger Co., 1993; 197-215.
57. Gau N. Beta-Hydroxbutyric acid. In: Amedeo JP, Lawrence AK, eds. Methods in Clinical Chemistry, 1St Ed. St. Louis, MO: C.V. Mosby Co., 1987; 101-104.
58. Cejka J, Kithier K. Serum carnitine quantification. Clin Chem 1992; 38: 304-305.
59. Ruddy TD, Shumak SL, Liu PP, Barnil A, Seawright SJ, McLaughlin PR, Zinman B. The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type I diabetes mellitus. J Clin Endocrinol Metab 1988; 66: 113-118.
60. Malone JI, Schocken DD, Morrison AD, Gilbert-Barness E. Diabetic cardiomyopathy and carnitine deficiency. J Diabetes Complications 1999; 13: 86-90.
61. Vary TC, Neely JR. Sodium dependence on carnitine transport in isolated perfused adult rat hearts. Am J Physiol 1983; 244: H247-252.
62. Vary TC, Neely JR. A mechanism for reduced myocardial carnitine levels in diabetic animals. Am J Physiol 1982; 243: H154-158.